NASDAQ: AMGN - Amgen

Rentabilität für sechs Monate: -3.84%
Dividendenrendite: +2.92%
Sektor: Healthcare

Nachricht Telegramm
FTC sues to stop Amgen’s $27.8B deal for Horizon Therapeutics

18 november 17:52 FTC sues to stop Amgen’s $27.8B deal for Horizon Therapeutics

Biden pushes Congress to allow Medicare to negotiate drug prices

18 november 16:20 Biden pushes Congress to allow Medicare to negotiate drug prices